Relmada Therapeutics Inc (RLMD) financials · $692.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Relmada Therapeutics Inc (RLMD) $692.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$59.1M | -$83.9M |
| Net Income | -$57.4M | -$80.0M |
| EPS (Diluted) | -$1.45 | -$2.65 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $94.0M | $45.8M |
| Current Assets | $94.0M | $45.8M |
| Cash & Equivalents | $3.50M | $3.86M |
| Total Liabilities | $7.49M | $10.3M |
| Current Liabilities | $6.43M | $10.3M |
| Shareholders' Equity | $86.5M | $35.5M |
| Retained Earnings | -$698.3M | -$640.9M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$45.8M | -$51.8M |
| Investing Cash Flow | -$48.1M | $51.6M |
| Financing Cash Flow | $93.6M | -$40.3K |
FAQ
What is RLMD P/E and revenue?
Relmada Therapeutics Inc (RLMD) $692.3M cap.
What is RLMD revenue?
RLMD income-statement cache has no revenue figure yet.
Is RLMD profitable?
Relmada Therapeutics Inc last cached net income is -$57.4M (FY2025).
What are RLMD total assets?
Relmada Therapeutics Inc last cached total assets are $94.0M (FY2025).
What is RLMD free cash flow?
No cached cash-flow row for RLMD yet.
Not investment advice. Cached statements, not a live tape.